Autoimmune diseases: MIF as a therapeutic target

被引：68
|
作者：
Greven, Dorothee [1 ]
Leng, Lin [2 ]
Bucala, Richard [2 ]
机构：
[1] Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands
[2] Yale Univ, Rheumatol Sect, New Haven, CT 06510 USA
来源：
EXPERT OPINION ON THERAPEUTIC TARGETS | 2010年 / 14卷 / 03期
关键词：
MIGRATION-INHIBITORY FACTOR; JUVENILE IDIOPATHIC ARTHRITIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; FACTOR GENE POLYMORPHISM; INNATE IMMUNE-RESPONSES; RHEUMATOID-ARTHRITIS; REGULATORY ROLE; PROINFLAMMATORY FUNCTION; PROMOTER POLYMORPHISMS; CRYSTAL-STRUCTURE;
D O I：
10.1517/14728220903551304
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Areas covered in this review: Our aim is to discuss MIF-directed therapies as a novel therapeutic approach. The review covers literature from the past 10 years. What the reader will gain: MIF inhibition has been shown to be efficacious in many experimental and pre-clinical studies of autoimmune inflammatory diseases. The close regulatory relationship between MIF and glucocorticoids makes therapeutic antagonism of MIF a potential steroid-sparing therapy in patients with refractory autoimmune diseases. Take home message: We expect that MIF antagonism by either small-molecule- or antibody-based approaches will find wide application in the treatment of autoimmune inflammatory diseases. Such therapy also may be informed by the MIF genotype of affected patients.
引用
收藏
页码：253 / 264
页数：12
相关论文
共 50 条
  • [21] MIF, a potential therapeutic target for rheumatoid arthritis?
    Zhaolin Chen
    Taotao Ma
    Cheng Huang
    Lei Zhang
    Tingting Hu
    Jun Li
    Rheumatology International, 2014, 34 : 1481 - 1482
  • [22] VAV1 as a putative therapeutic target in autoimmune and chronic inflammatory fl ammatory diseases
    Neurath, Markus F.
    Berg, Leslie J.
    TRENDS IN IMMUNOLOGY, 2024, 45 (08) : 580 - 596
  • [23] The role of inflammation in autoimmune disease: a therapeutic target
    Xiang, Yu
    Zhang, Mingxue
    Jiang, Die
    Su, Qian
    Shi, Jianyou
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [24] The role of flavonoids in autoimmune diseases: Therapeutic updates
    Rengasamy, Kannan R. R.
    Khan, Haroon
    Gowrishankar, Shanmugaraj
    Lagoa, Ricardo J. L.
    Mahomoodally, Fawzi M.
    Khan, Ziyad
    Suroowan, Shanoo
    Tewari, Devesh
    Zengin, Gokhan
    Hassan, Sherif T. S.
    Pandian, Shunmugiah Karutha
    PHARMACOLOGY & THERAPEUTICS, 2019, 194 : 107 - 131
  • [25] The B cell: a new therapeutic target in rheumatoid arthritis and other autoimmune diseases
    Mariette, X
    JOINT BONE SPINE, 2004, 71 (05) : 357 - 360
  • [26] T cell costimulation: A rational target in the therapeutic armamentarium for autoimmune diseases and transplantation
    Vincenti, Flavio
    Luggen, Michael
    ANNUAL REVIEW OF MEDICINE, 2007, 58 : 347 - 358
  • [27] The neonatal Fc receptor as therapeutic target in IgG-mediated autoimmune diseases
    Sesarman, Alina
    Vidarsson, Gestur
    Sitaru, Cassian
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2010, 67 (15) : 2533 - 2550
  • [28] B7-H3: A promising therapeutic target for autoimmune diseases
    Chen, Yuting
    Guan, Shi-Yang
    Deng, Jixiang
    Yang, Hui
    Xu, Wei
    Xu, Shanshan
    Shao, Ming
    Gao, Xing
    Xu, Shengqian
    Shuai, Zongwen
    Pan, Faming
    CELLULAR IMMUNOLOGY, 2020, 352
  • [29] CCR6-CCL20 axis as a therapeutic target for autoimmune diseases
    Meitei, Heikrujam Thoihen
    Jadhav, Nandadeep
    Lal, Girdhari
    AUTOIMMUNITY REVIEWS, 2021, 20 (07)
  • [30] IL-12 family cytokines and autoimmune diseases: A potential therapeutic target?
    Cui, Xiaoyu
    Liu, Wu
    Jiang, Hanxue
    Zhao, Qihan
    Hu, Yuehong
    Tang, Xinyue
    Liu, Xianli
    Dai, Haoran
    Rui, Hongliang
    Liu, Baoli
    JOURNAL OF TRANSLATIONAL AUTOIMMUNITY, 2025, 10
12345